0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rapid Influenza Diagnostic Test (RIDT) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-29I91
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Rapid Influenza Diagnostic Test RIDT Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Rapid Influenza Diagnostic Test (RIDT) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-29I91
Report
September 2022
122 Pages
QYResearch
Region: North America, Europe, Asia Pacific, South America, Global, Africa, Middle East
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Rapid Influenza Diagnostic Test (RIDT) market is projected to reach US$ 2336.3 million by 2028 from an estimated US$ 1393 million in 2022, at a CAGR of 9.0% during 2023 and 2028.

Americas is the largest Rapid Influenza Diagnostic Test (RIDT) market with about 58% market share. Europe is follower, accounting for about 25% market share.
The key players are BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics), Wondfo, Beijing Wantai Biological Pharmacy etc. Top 3 companies occupied about 49% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rapid Influenza Diagnostic Test (RIDT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Rapid Influenza Diagnostic Test (RIDT).
The Rapid Influenza Diagnostic Test (RIDT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Rapid Influenza Diagnostic Test (RIDT) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Influenza Diagnostic Test (RIDT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)
Wondfo
Beijing Wantai Biological Pharmacy
Product Type Insights
Global markets are presented by Rapid Influenza Diagnostic Test (RIDT) type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Rapid Influenza Diagnostic Test (RIDT) are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Rapid Influenza Diagnostic Test (RIDT) Segment by Type

Digital RIDTs
Conventional RIDT
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Rapid Influenza Diagnostic Test (RIDT) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Rapid Influenza Diagnostic Test (RIDT) market.

Rapid Influenza Diagnostic Test (RIDT) Segment by Application

Hospitals
POCT
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Rapid Influenza Diagnostic Test (RIDT) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rapid Influenza Diagnostic Test (RIDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Rapid Influenza Diagnostic Test (RIDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Rapid Influenza Diagnostic Test (RIDT) industry.
This report helps stakeholders to gain insights into which regions to target globally.
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rapid Influenza Diagnostic Test (RIDT).

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

1 Study Coverage
1.1 Rapid Influenza Diagnostic Test (RIDT) Product Introduction
1.2 Market by Type
1.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Digital RIDTs
1.2.3 Conventional RIDT
1.3 Market by Application
1.3.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Estimates and Forecasts
2.2 Rapid Influenza Diagnostic Test (RIDT) Market Size by Region: 2022 Versus 2028
2.2.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Region: 2017-2022
2.2.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Forecast by Region (2023-2028)
2.2.3 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Region (2017-2028)
3 Global Rapid Influenza Diagnostic Test (RIDT) by Company
3.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Company (2017-2022)
3.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Rapid Influenza Diagnostic Test (RIDT) Companies around the World: Ranking by Revenue
3.3.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Rapid Influenza Diagnostic Test (RIDT) Companies Headquarters & Product Type
3.4.1 Rapid Influenza Diagnostic Test (RIDT) Companies Headquarters
3.4.2 Global Rapid Influenza Diagnostic Test (RIDT) Companies Product & Service
3.4.3 Date of International Companies Enter into Rapid Influenza Diagnostic Test (RIDT) Market
3.5 Global Rapid Influenza Diagnostic Test (RIDT) Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 BD
4.1.1 BD Corporation Information
4.1.2 BD Description, Business Overview
4.1.3 BD Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.1.4 BD Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.1.5 BD Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.1.6 BD Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.1.7 BD Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.1.8 BD Recent Developments
4.2 Abbot (Alere)
4.2.1 Abbot (Alere) Corporation Information
4.2.2 Abbot (Alere) Description, Business Overview
4.2.3 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.2.4 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.2.5 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.2.6 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.2.7 Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.2.8 Abbot (Alere) Recent Developments
4.3 Quidel
4.3.1 Quidel Corporation Information
4.3.2 Quidel Description, Business Overview
4.3.3 Quidel Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.3.4 Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.3.5 Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.3.6 Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.3.7 Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.3.8 Quidel Recent Developments
4.4 Roche
4.4.1 Roche Corporation Information
4.4.2 Roche Description, Business Overview
4.4.3 Roche Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.4.4 Roche Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.4.5 Roche Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.4.6 Roche Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.4.7 Roche Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.4.8 Roche Recent Developments
4.5 Thermo Fisher Scientific
4.5.1 Thermo Fisher Scientific Corporation Information
4.5.2 Thermo Fisher Scientific Description, Business Overview
4.5.3 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.5.4 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.5.5 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.5.6 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.5.7 Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.5.8 Thermo Fisher Scientific Recent Developments
4.6 Meridian Bioscience
4.6.1 Meridian Bioscience Corporation Information
4.6.2 Meridian Bioscience Description, Business Overview
4.6.3 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.6.4 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.6.5 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.6.6 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.6.7 Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.6.8 Meridian Bioscience Recent Development
4.7 Analytik Jena
4.7.1 Analytik Jena Corporation Information
4.7.2 Analytik Jena Description, Business Overview
4.7.3 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.7.4 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.7.5 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.7.6 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.7.7 Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.7.8 Analytik Jena Recent Development
4.8 Princeton BioMeditech Corporation
4.8.1 Princeton BioMeditech Corporation Corporation Information
4.8.2 Princeton BioMeditech Corporation Description, Business Overview
4.8.3 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.8.4 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.8.5 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.8.6 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.8.7 Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.8.8 Princeton BioMeditech Corporation Recent Development
4.9 BioMerieux
4.9.1 BioMerieux Corporation Information
4.9.2 BioMerieux Description, Business Overview
4.9.3 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.9.4 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.9.5 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.9.6 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.9.7 BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.9.8 BioMerieux Recent Development
4.10 Sekisui Diagnostics
4.10.1 Sekisui Diagnostics Corporation Information
4.10.2 Sekisui Diagnostics Description, Business Overview
4.10.3 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.10.4 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.10.5 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.10.6 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.10.7 Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.10.8 Sekisui Diagnostics Recent Development
4.11 Response Biomedical
4.11.1 Response Biomedical Corporation Information
4.11.2 Response Biomedical Description, Business Overview
4.11.3 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.11.4 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.11.5 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.11.6 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.11.7 Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.11.8 Response Biomedical Recent Development
4.12 SA Scientific
4.12.1 SA Scientific Corporation Information
4.12.2 SA Scientific Description, Business Overview
4.12.3 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.12.4 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.12.5 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.12.6 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.12.7 SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.12.8 SA Scientific Recent Development
4.13 DiaSorin (Focus Diagnostics)
4.13.1 DiaSorin (Focus Diagnostics) Corporation Information
4.13.2 DiaSorin (Focus Diagnostics) Description, Business Overview
4.13.3 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.13.4 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.13.5 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.13.6 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.13.7 DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.13.8 DiaSorin (Focus Diagnostics) Recent Development
4.14 Wondfo
4.14.1 Wondfo Corporation Information
4.14.2 Wondfo Description, Business Overview
4.14.3 Wondfo Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.14.4 Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.14.5 Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.14.6 Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.14.7 Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.14.8 Wondfo Recent Development
4.15 Beijing Wantai Biological Pharmacy
4.15.1 Beijing Wantai Biological Pharmacy Corporation Information
4.15.2 Beijing Wantai Biological Pharmacy Description, Business Overview
4.15.3 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Products Offered
4.15.4 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue and Gross Margin (2017-2022)
4.15.5 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue by Product in 2021
4.15.6 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue by Application in 2021
4.15.7 Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue by Geographic Area in 2021
4.15.8 Beijing Wantai Biological Pharmacy Recent Development
5 Breakdown Data by Type
5.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022)
5.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Forecast by Type (2023-2028)
5.3 Rapid Influenza Diagnostic Test (RIDT) Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022)
6.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Forecast by Application (2023-2028)
6.3 Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Rapid Influenza Diagnostic Test (RIDT) Market Size YoY Growth 2017-2028
7.2 North America Rapid Influenza Diagnostic Test (RIDT) Market Facts & Figures by Country (2017-2028)
7.3 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022)
7.4 North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022)
8.4 Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022)
9 Europe
9.1 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size YoY Growth 2017-2028
9.2 Europe Rapid Influenza Diagnostic Test (RIDT) Market Facts & Figures by Country (2017-2028)
9.3 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022)
9.4 Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Rapid Influenza Diagnostic Test (RIDT) Market Size YoY Growth 2017-2028
10.2 Latin America Rapid Influenza Diagnostic Test (RIDT) Market Facts & Figures by Country (2017-2028)
10.3 Latin America Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022)
10.4 Latin America Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022)
11.4 Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Rapid Influenza Diagnostic Test (RIDT) Supply Chain Analysis
12.2 Rapid Influenza Diagnostic Test (RIDT) Key Raw Materials and Upstream Suppliers
12.3 Rapid Influenza Diagnostic Test (RIDT) Clients Analysis
12.4 Rapid Influenza Diagnostic Test (RIDT) Sales Channel and Sales Model Analysis
12.4.1 Rapid Influenza Diagnostic Test (RIDT) Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Rapid Influenza Diagnostic Test (RIDT) Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Rapid Influenza Diagnostic Test (RIDT) Distributors
13 Market Dynamics
13.1 Rapid Influenza Diagnostic Test (RIDT) Industry Trends
13.2 Rapid Influenza Diagnostic Test (RIDT) Market Drivers
13.3 Rapid Influenza Diagnostic Test (RIDT) Market Challenges
13.4 Rapid Influenza Diagnostic Test (RIDT) Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Companies of Digital RIDTs
    Table 3. Major Companies of Conventional RIDT
    Table 4. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Region (US$ Million): 2022 VS 2028
    Table 6. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Region (2017-2022) & (US$ Million)
    Table 7. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 8. Rapid Influenza Diagnostic Test (RIDT) Revenue by Company (2017-2022) & (US$ Million)
    Table 9. Rapid Influenza Diagnostic Test (RIDT) Revenue Share by Company (2017-2022)
    Table 10. Ranking of Global Top Rapid Influenza Diagnostic Test (RIDT) Players by Revenue (US$ Million) in 2021
    Table 11. Global Rapid Influenza Diagnostic Test (RIDT) Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 12. Global Rapid Influenza Diagnostic Test (RIDT) by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rapid Influenza Diagnostic Test (RIDT) as of 2021)
    Table 13. Global Rapid Influenza Diagnostic Test (RIDT) Companies Headquarters
    Table 14. Global Rapid Influenza Diagnostic Test (RIDT) Companies Product & Service
    Table 15. Date of International Companies Enter into Rapid Influenza Diagnostic Test (RIDT) Market
    Table 16. Global Rapid Influenza Diagnostic Test (RIDT) Mergers & Acquisitions, Expansion Plans
    Table 17. BD Corporation Information
    Table 18. BD Description and Business Overview
    Table 19. BD Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 20. BD Rapid Influenza Diagnostic Test (RIDT) Product
    Table 21. BD Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 22. BD Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 23. BD Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 24. BD Recent Development
    Table 25. Abbot (Alere) Corporation Information
    Table 26. Abbot (Alere) Description and Business Overview
    Table 27. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 28. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Product
    Table 29. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 30. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 31. Abbot (Alere) Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 32. Abbot (Alere) Recent Development
    Table 33. Quidel Corporation Information
    Table 34. Quidel Description and Business Overview
    Table 35. Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 36. Quidel Rapid Influenza Diagnostic Test (RIDT) Product
    Table 37. Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 38. Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 39. Quidel Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 40. Quidel Recent Development
    Table 41. Roche Corporation Information
    Table 42. Roche Description and Business Overview
    Table 43. Roche Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 44. Roche Rapid Influenza Diagnostic Test (RIDT) Product
    Table 45. Roche Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 46. Roche Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 47. Roche Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 48. Roche Recent Development
    Table 49. Thermo Fisher Scientific Corporation Information
    Table 50. Thermo Fisher Scientific Description and Business Overview
    Table 51. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 52. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Product
    Table 53. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 54. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 55. Thermo Fisher Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 56. Thermo Fisher Scientific Recent Development
    Table 57. Meridian Bioscience Corporation Information
    Table 58. Meridian Bioscience Description and Business Overview
    Table 59. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 60. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Product
    Table 61. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 62. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 63. Meridian Bioscience Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 64. Analytik Jena Corporation Information
    Table 65. Analytik Jena Description and Business Overview
    Table 66. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 67. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Product
    Table 68. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 69. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 70. Analytik Jena Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 71. Princeton BioMeditech Corporation Corporation Information
    Table 72. Princeton BioMeditech Corporation Description and Business Overview
    Table 73. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 74. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Product
    Table 75. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 76. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 77. Princeton BioMeditech Corporation Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 78. BioMerieux Corporation Information
    Table 79. BioMerieux Description and Business Overview
    Table 80. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 81. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Product
    Table 82. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 83. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 84. BioMerieux Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 85. Sekisui Diagnostics Corporation Information
    Table 86. Sekisui Diagnostics Description and Business Overview
    Table 87. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 88. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Product
    Table 89. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 90. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 91. Sekisui Diagnostics Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 92. Response Biomedical Corporation Information
    Table 93. Response Biomedical Description and Business Overview
    Table 94. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 95. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Product
    Table 96. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 97. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 98. Response Biomedical Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 99. SA Scientific Corporation Information
    Table 100. SA Scientific Description and Business Overview
    Table 101. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 102. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Product
    Table 103. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 104. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 105. SA Scientific Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 106. DiaSorin (Focus Diagnostics) Corporation Information
    Table 107. DiaSorin (Focus Diagnostics) Description and Business Overview
    Table 108. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 109. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Product
    Table 110. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 111. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 112. DiaSorin (Focus Diagnostics) Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 113. Wondfo Corporation Information
    Table 114. Wondfo Description and Business Overview
    Table 115. Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 116. Wondfo Rapid Influenza Diagnostic Test (RIDT) Product
    Table 117. Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 118. Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 119. Wondfo Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 120. Beijing Wantai Biological Pharmacy Corporation Information
    Table 121. Beijing Wantai Biological Pharmacy Description and Business Overview
    Table 122. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 123. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Product
    Table 124. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Product in 2021
    Table 125. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Application in 2021
    Table 126. Beijing Wantai Biological Pharmacy Rapid Influenza Diagnostic Test (RIDT) Revenue Proportion of Rapid Influenza Diagnostic Test (RIDT) by Geographic Area in 2021
    Table 127. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022) & (US$ Million)
    Table 128. Global Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022) & (US$ Million)
    Table 129. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 130. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2017-2022) & (US$ Million)
    Table 131. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2023-2028) & (US$ Million)
    Table 132. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022) & (US$ Million)
    Table 133. North America Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022) & (US$ Million)
    Table 134. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue by Region (2017-2028) & (US$ Million)
    Table 135. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue by Region (2023-2028) & (US$ Million)
    Table 136. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022) & (US$ Million)
    Table 137. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022) & (US$ Million)
    Table 138. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2017-2022) & (US$ Million)
    Table 139. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2023-2028) & (US$ Million)
    Table 140. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022) & (US$ Million)
    Table 141. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022) & (US$ Million)
    Table 142. Latin America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2017-2022) & (US$ Million)
    Table 143. Latin America Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2023-2028) & (US$ Million)
    Table 144. Latin America Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022) & (US$ Million)
    Table 145. Latin America Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022) & (US$ Million)
    Table 146. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2017-2022) & (US$ Million)
    Table 147. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue by Country (2023-2028) & (US$ Million)
    Table 148. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue by Type (2017-2022) & (US$ Million)
    Table 149. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue by Application (2017-2022) & (US$ Million)
    Table 150. Rapid Influenza Diagnostic Test (RIDT) Key Raw Materials, Industry Status and Trend
    Table 151. Rapid Influenza Diagnostic Test (RIDT) Key Raw Materials and Upstream Suppliers
    Table 152. Rapid Influenza Diagnostic Test (RIDT) Clients Status and Trend
    Table 153. Rapid Influenza Diagnostic Test (RIDT) Typical Clients
    Table 154. Rapid Influenza Diagnostic Test (RIDT) Distributors
    Table 155. Rapid Influenza Diagnostic Test (RIDT) Market Trends
    Table 156. Rapid Influenza Diagnostic Test (RIDT) Market Drivers
    Table 157. Rapid Influenza Diagnostic Test (RIDT) Market Challenges
    Table 158. Rapid Influenza Diagnostic Test (RIDT) Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rapid Influenza Diagnostic Test (RIDT) Product Picture
    Figure 2. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Type in 2021 & 2028
    Figure 3. Digital RIDTs Product Picture
    Figure 4. Conventional RIDT Product Picture
    Figure 5. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application in 2021 & 2028
    Figure 6. Hospitals
    Figure 7. POCT
    Figure 8. Others
    Figure 9. Rapid Influenza Diagnostic Test (RIDT) Report Years Considered
    Figure 10. Global Rapid Influenza Diagnostic Test (RIDT) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Rapid Influenza Diagnostic Test (RIDT) Market Size 2017-2028 (US$ Million)
    Figure 12. Global Rapid Influenza Diagnostic Test (RIDT) Market Size Market Share by Region: 2022 Versus 2028
    Figure 13. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Region (2017-2028)
    Figure 14. Rapid Influenza Diagnostic Test (RIDT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share Forecast by Type (2017-2028)
    Figure 16. Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share Forecast by Application (2017-2028)
    Figure 17. North America Rapid Influenza Diagnostic Test (RIDT) Revenue 2017-2028 (US$ Million)
    Figure 18. North America Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Type (2017-2022)
    Figure 19. North America Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2017-2022)
    Figure 20. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue 2017-2028 (US$ Million)
    Figure 21. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Region (2017-2028)
    Figure 22. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Type (2017-2022)
    Figure 23. Asia-Pacific Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2017-2022)
    Figure 24. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 25. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Country (2017-2028)
    Figure 26. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Type (2017-2022)
    Figure 27. Europe Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2017-2022)
    Figure 28. Latin America Rapid Influenza Diagnostic Test (RIDT) Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 29. Latin America Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Country (2017-2022)
    Figure 30. Latin America Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Type (2017-2022)
    Figure 31. Latin America Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2017-2022)
    Figure 32. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 33. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Country (2017-2028)
    Figure 34. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Type (2017-2022)
    Figure 35. Middle East and Africa Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by Application (2017-2022)
    Figure 36. Rapid Influenza Diagnostic Test (RIDT) Supply Chain (Upstream and Downstream Market)
    Figure 37. Global Production Market Share of Rapid Influenza Diagnostic Test (RIDT) Raw Materials by Region in 2021
    Figure 38. Rapid Influenza Diagnostic Test (RIDT) Distribution Channels
    Figure 39. Global Rapid Influenza Diagnostic Test (RIDT) Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 40. Global Rapid Influenza Diagnostic Test (RIDT) Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 41. Bottom-up and Top-down Approaches for This Report
    Figure 42. Data Triangulation
    Figure 43. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS